TAKE THE NEXT STEP IN
PEANUT ALLERGY MANAGEMENT
Better allergy de nition for improved quality of life
With ImmunoCAP® Molecular Allergology, you can take
the diagnosis and management of peanut allergy to a
whole new level. Unlike traditional testing, the technology
uses single allergen components to quantitatively detect
IgE antibodies – a level of insight previously unimaginable.
A single blood sample enables a measurement of all
available ImmunoCAP® peanut components, giving you a
complete risk assessment. ImmunoCAP® Allergen Compo-
nents help you di erentiate between“true”allergies and
symptoms due to cross-reactivity, evaluate the risk of severe
reactions and de ne the optimal treatment. Bene ts that
ultimately can help improve the patient’s quality of life.
To learn more about the advancements we’re making in allergy and autoimmunity testing, contact your local Phadia (now Thermo Fisher Scienti c)
representative or visit
c.com/phadia
heart.se
c.com/phadia
